SCHEMBL22242602

SCHEMBL22242602

C=C(C)C(=O)Oc1ccc(C(=O)n2ccnc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.50
KMT2A Q03164 4/20 0.44
ATM Q13315 1/20 0.44
CYP19A1 P11511 3/20 0.39
CYP3A4 P08684 1/20 0.38
BAZ2B Q9UIF8 1/20 0.38
TBXAS1 P24557 7/20 0.37
HTT P42858 2/20 0.36
POLB P06746 1/20 0.36
APEX1 P27695 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 1/20 0.36
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11110140 0.80 CYP19A1 (0.55) KMT2ACYP19A1TBXAS1MAPTLMNA
SCHEMBL13028396 0.79 FAAH (0.46) KMT2ACYP19A1CYP3A4BAZ2BTBXAS1
SCHEMBL9807751 0.79 CYP19A1 (0.46) CYP19A1CYP3A4BAZ2BTBXAS1HTT
SCHEMBL11959239 0.77 ELANE (0.41) ELANEKMT2ACYP19A1CYP3A4TBXAS1
SCHEMBL28771065 0.75 CYP1A2 (0.41) KMT2AATMCYP19A1CYP3A4MAPT
SCHEMBL11106769 0.75 MAOB (0.46) ELANEKMT2ACYP19A1CYP3A4BAZ2B
SCHEMBL13028408 0.74 ADH5 (0.51) CYP19A1CYP3A4BAZ2BHTTMAPT
SCHEMBL18280922 0.74 HTT (0.63) KMT2ATBXAS1HTTTDP1MAPT
SCHEMBL22446127 0.74 CYP19A1 (0.35) ELANEKMT2AATMCYP19A1CYP3A4
SCHEMBL56436 0.73 ELANE (0.69) ELANEKMT2AATMCYP3A4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11640114-B2 Compound, resin, photoresist composition and process for producing photoresist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-02 US disclosed
US-11640114-B2 Compound, resin, photoresist composition and process for producing photoresist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-02 US disclosed
US-11214635-B2 Compound, resin, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-01-04 US disclosed
EP-3581594-B1 COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL CO (JP) 2021-12-29 EP disclosed
US-20200326625-A1 COMPOUND, RESIN, PHOTORESIST COMPOSITION AND PROCESS FOR PRODUCING PHOTORESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-10-15 US disclosed
US-10747111-B2 Compound, resin, photoresist composition and process for producing photoresist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-08-18 US disclosed
US-20200231720-A1 COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200326625-A1 COMPOUND, RESIN, PHOTORESIST COMPOSITION AND PROCESS FOR PRODUCING PHOTORESIST PATTERN HAX1, BRIX1, RXRA ELANE 1189/4885KMT2A 1657/4885ATM 1205/4885
US-10747111-B2 Compound, resin, photoresist composition and process for producing photoresist pattern HAX1, BRIX1, RXRA ELANE 1189/4885KMT2A 1657/4885ATM 1205/4885
US-11640114-B2 Compound, resin, photoresist composition and process for producing photoresist pattern HAX1, BRIX1, RXRA ELANE 1189/4885KMT2A 1657/4885ATM 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.